Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.
about
Effects of dantrolene and its derivatives on Ca(2+) release from the sarcoplasmic reticulum of mouse skeletal muscle fibresFunctional role of neuroendocrine-specific protein-like 1 in membrane translocation of GLUT4Ryanodine receptor channelopathies.Management of malignant hyperthermia: diagnosis and treatment.Dantrolene reduces the threshold and gain for shiveringAccelerated activation of SOCE current in myotubes from two mouse models of anesthetic- and heat-induced sudden death.A comparison of the effects of sodium thiocyanate and dantrolene sodium on a mammalian isolated skeletal muscle.Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.Autosomal dominant multicore disease.Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unitTargeting ryanodine receptors for anti-arrhythmic therapy.Hypothesis: exertional heat stroke-induced myopathy and genetically inherited malignant hyperthermia represent the same disorder, the human stress syndrome.Dexmedetomidine as part of balanced anesthesia care in children with malignant hyperthermia risk and egg allergy.Malignant hyperthermia in the early days of pediatric anesthesia: an interview with anesthesiology pioneer, Dr. John F. Ryan.Dexmedetomidine as the primary anesthetic agent during cardiac surgery in an infant with a family history of malignant hyperthermia.The effect of dantrolene on skeletal-muscle sarcoplasmic-reticulum function in malignant hyperpyrexia in pigs.Preparation of Injectable Dantrolene for Emergency Treatment of Malignant Hyperthermia-like Syndromes.Ca-induced Ca release in malignant hyperthermia-susceptible pig skeletal muscle.Successful early application of extracorporeal membrane oxygenation to support cardiopulmonary resuscitation for a patient suffering from severe malignant hyperthermia and cardiac arrest: a case report.Anesthesiology-epitomes of progress: malignant hyperthermia: an update.Mind the magnesium, in dantrolene suppression of malignant hyperthermia.Studies on normal human skeletal muscle in relation to the pathopharmacology of malignant hyperpyrexia.When best evidence is rarer than the disease.JSA guideline for the management of malignant hyperthermia crisis 2016.Identification of dantrolene binding sites in porcine skeletal muscle sarcoplasmic reticulum.The malignant hyperthermia syndrome: an unusual complication of anesthesia.
P2860
Q28362041-968683AD-AA1C-4379-B114-CAB86F44709DQ28584856-DF0474D3-C32A-49D6-8E5B-6AB9AF087380Q33912937-A6FD7642-18F4-4202-8E47-09D39C1FA985Q34421643-B0E87213-8C58-4AAB-9A79-C31A59727C57Q34583099-4B1FF262-4702-4D4D-A1E2-81E2CE33BC7EQ35021801-E048A608-C0A6-4B7F-97C0-A61F588E22B7Q35176931-9A0A1FDD-E932-4FCA-ADC3-30BDB80D5EB8Q36279483-DFC61508-81F6-49B8-9B38-8F46E5D5D075Q37020693-E6FE3AA6-7726-4E31-8726-D614740CAE9DQ37241897-5361914C-A8BB-4C6D-B2EB-352AF4FDB5E8Q37885158-A7E83240-373C-437F-9734-AFA659C2F6C6Q38221827-8169F8AF-6300-4C1C-9DDC-D326B04275CEQ38945613-C9D7AE9E-E8F5-4D79-9BBB-FC75D4F89D7FQ39277843-D7909A76-45CF-491D-8441-32080CA66529Q39483878-6FCA642B-568F-4434-B661-07BC37D7775AQ41821025-87DA09A6-8A5B-4BC7-9754-35E458E3264BQ41822797-AAA6D20F-D5A3-4959-9339-467601A14538Q41836669-32503EBB-4C0A-4F17-8529-4F549769C9C2Q42230616-E82F873E-F272-42CE-A444-F312D1537094Q42544748-33A4D1B0-2129-41F5-A2B4-539E587D3EA0Q43083643-EF449A38-70B2-418E-9F7C-F79AAB7EDFA8Q45180154-686227F7-B902-4B09-AB7F-294622158215Q46541105-7D1ABB42-BDDA-4175-93FE-38CD5873F936Q47324823-6B5AA207-14F0-439F-942C-0D38E697F406Q51596813-FBD108C2-7278-49E4-9D0F-61F4AD505896Q52708517-A3FA3FE7-D9DC-4EDE-8FE9-64553EF09D89
P2860
Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.
description
1975 nî lūn-bûn
@nan
1975 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.
@ast
Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.
@en
type
label
Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.
@ast
Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.
@en
prefLabel
Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.
@ast
Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.
@en
P356
P1476
Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.
@en
P2093
Harrison GG
P356
10.1093/BJA/47.1.62
P407
P577
1975-01-01T00:00:00Z